Grifols (GRFS) Inventory Average (2011 - 2025)

Grifols (GRFS) reported Inventory Average of $3.8 billion for Q4 2025, up 108.15% on a YoY basis from $1.8 billion in Q4 2024, and up 108.15% quarter-over-quarter from $1.8 billion in Q4 2024.

Grifols (GRFS) Inventory Average (2011 - 2025) Analysis & Trends

Grifols has reported Inventory Average for 15 years, with the latest figure at $3.8 billion in Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 108.15% year-over-year to $3.8 billion; the trailing twelve-month figure through Dec 2025 stood at $3.8 billion (up 108.15% YoY), and the FY2025 full-year result was $3.8 billion, up 108.15% from the prior year.
  • Inventory Average for Q4 2025 stood at $3.8 billion, up from $1.8 billion in the prior quarter.
  • The five-year high for Inventory Average was $3.8 billion in Q4 2025, with the low at -$163.9 million in Q4 2021.
  • Historically, Inventory Average has averaged $1.0 billion across 5 years, with a median of -$110.1 million in 2023.
  • Annual changes were most pronounced in 2021 — Inventory Average tumbled 115.08% — and 2024, when it surged 1767.5%.
  • Grifols' Inventory Average stood at -$163.9 million in 2021, then gained by 18.14% to -$134.1 million in 2022, then advanced by 17.95% to -$110.1 million in 2023, then surged by 1767.5% to $1.8 billion in 2024, then jumped by 108.15% to $3.8 billion in 2025.
  • The last three Inventory Average figures came in at $3.8 billion (Q4 2025), $1.8 billion (Q4 2024), and -$110.1 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 8.09 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 14.14 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 14.39 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 5.00 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 6.57 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 6.21 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.84 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 10.66 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 2.72 Bn
10 Grifols 6.05 Bn 5.09 Bn - 3.82 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.82 Bn
Dec 31, 2024 1.84 Bn
Dec 31, 2023 -110.07 Mn
Dec 31, 2022 -134.15 Mn
Dec 31, 2021 -163.88 Mn
Dec 31, 2020 1.09 Bn
Sep 30, 2020 2.52 Bn
Mar 31, 2020 2.65 Bn
Dec 31, 2019 2.59 Bn
Sep 30, 2019 2.50 Bn
Mar 31, 2019 2.31 Bn
Dec 31, 2018 2.20 Bn
Sep 30, 2018 2.16 Bn
Jun 30, 2018 2.11 Bn
Mar 31, 2018 1.99 Bn
Dec 31, 2017 1.84 Bn
Dec 31, 2016 1.75 Bn
Sep 30, 2016 1.73 Bn
Dec 31, 2015 1.54 Bn
Mar 31, 2015 1.52 Bn